Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,665 Cr₹1,817 Cr₹1,669 Cr₹1,541 Cr₹1,242 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,665 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,665 Cr
Mar2024₹1,817 Cr
Mar2023₹1,669 Cr
Mar2022₹1,541 Cr
Mar2021₹1,242 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2025 ₹1,665 Cr
-8.38
Mar2024 ₹1,817 Cr
8.91
Mar2023 ₹1,669 Cr
8.30
Mar2022 ₹1,541 Cr
24.10
Mar2021 ₹1,242 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,706.6 Cr -2.2% -7.3% -22.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-2.2%

-7.3%

-22.3%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses